Rectal Adenocarcinoma with Synchronous Brain Metastasis and Prolonged Overall Survival (OS)

Article ID

MH809

Rectal Adenocarcinoma with Synchronous Brain Metastasis and Prolonged Overall Survival (OS)

Losada Vila B
Losada Vila B
Gutirrez Abad D
Gutirrez Abad D
De Torres Olombrada MV
De Torres Olombrada MV
Pereira Prez F
Pereira Prez F
DOI

Abstract

A 61 years old woman with dizziness and gait disturbance in relation to brain metastases of a rectal adenocarcinoma (cT3N1M1). CT showed an unique frontal lesion and no further disease in other organs. Performance Status 1, so Digestive Tumors Committee decides surgical treatment of frontal brain metastasis and the histologic postsurgical examination showed microscopic affected margins. Then, radiation therapy (RT) of brain with radiosurgery and short course 5×5 of the primary tumor with low anterior resection was completed. After 2 months of brain RT, liver progression was discovered and then we decided neoadjuvant chemotherapy mFOLFOX6 and bevacizumab x 5 cycles with stable liver metastases and no other lesions. Following, limited liver resection and adjuvant chemotherapy was performed with the same schedule. No signs of tumor recurrence and more than 13 and 24 months of disease-free survival (DFS) and overall survival (OS) respectively was achieved in a metastasic cancer (brain metastasis) with usually OS 3 months.

Rectal Adenocarcinoma with Synchronous Brain Metastasis and Prolonged Overall Survival (OS)

A 61 years old woman with dizziness and gait disturbance in relation to brain metastases of a rectal adenocarcinoma (cT3N1M1). CT showed an unique frontal lesion and no further disease in other organs. Performance Status 1, so Digestive Tumors Committee decides surgical treatment of frontal brain metastasis and the histologic postsurgical examination showed microscopic affected margins. Then, radiation therapy (RT) of brain with radiosurgery and short course 5×5 of the primary tumor with low anterior resection was completed. After 2 months of brain RT, liver progression was discovered and then we decided neoadjuvant chemotherapy mFOLFOX6 and bevacizumab x 5 cycles with stable liver metastases and no other lesions. Following, limited liver resection and adjuvant chemotherapy was performed with the same schedule. No signs of tumor recurrence and more than 13 and 24 months of disease-free survival (DFS) and overall survival (OS) respectively was achieved in a metastasic cancer (brain metastasis) with usually OS 3 months.

Losada Vila B
Losada Vila B
Gutirrez Abad D
Gutirrez Abad D
De Torres Olombrada MV
De Torres Olombrada MV
Pereira Prez F
Pereira Prez F

No Figures found in article.

B Losada Vila. 2017. “. Global Journal of Medical Research – F: Diseases GJMR-F Volume 17 (GJMR Volume 17 Issue F1): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Classification
GJMR-F Classification: NLMC Code: WB 344
Keywords
Article Matrices
Total Views: 3564
Total Downloads: 1799
2026 Trends
Research Identity (RIN)
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Rectal Adenocarcinoma with Synchronous Brain Metastasis and Prolonged Overall Survival (OS)

Losada Vila B
Losada Vila B
Gutirrez Abad D
Gutirrez Abad D
De Torres Olombrada MV
De Torres Olombrada MV
Pereira Prez F
Pereira Prez F

Research Journals